|3.||Open-Angle Glaucoma (Glaucoma, Open Angle)
|4.||Ocular Hypertension (Glaucoma, Suspect)
|5.||Angle-Closure Glaucoma (Glaucoma, Angle Closure)
|1.||Lam, Dennis S C: 18 articles (01/2015 - 06/2002)|
|2.||Tham, Clement C Y: 17 articles (05/2015 - 06/2002)|
|3.||Lai, Jimmy S M: 14 articles (01/2015 - 06/2002)|
|4.||Aung, Tin: 13 articles (07/2015 - 08/2002)|
|5.||Leung, Dexter Y L: 10 articles (05/2015 - 08/2005)|
|6.||Ge, Jian: 9 articles (07/2014 - 06/2007)|
|7.||Thomas, Ravi: 8 articles (12/2014 - 04/2004)|
|8.||Liu, Xing: 8 articles (06/2014 - 08/2008)|
|9.||Kwong, Yolanda Y Y: 7 articles (05/2015 - 12/2008)|
|10.||Li, Felix C H: 7 articles (05/2015 - 12/2008)|
|1.||latanoprost (Xalatan)FDA Link
01/01/2009 - "latanoprost, a prostaglandin analogue, is effective in reducing IOP in chronic angle closure glaucoma patients and its efficacy is not affected by the degree of angle closure by peripheral anterior synechiae."
02/01/2005 - "The aim of this study was to evaluate the efficacy of 0.005% latanoprost in lowering intraocular pressure (IOP) in patients with chronic angle-closure glaucoma (CACG) and no visible ciliary-body face. "
02/01/2005 - "Efficacy of latanoprost in patients with chronic angle-closure glaucoma and no visible ciliary-body face: a preliminary study."
08/01/2002 - "Two independent, prospective trials were recently conducted to assess the efficacy of latanoprost in reducing intraocular pressure (IOP) in patients with primary angle-closure glaucoma (PACG). "
01/01/2009 - "Efficacy of latanoprost in management of chronic angle closure glaucoma."
09/01/2002 - "To study whether argon laser peripheral iridoplasty (ALPI) is as effective and safe as conventional systemic medications in treatment of acute primary angle-closure glaucoma (PACG) when immediate laser peripheral iridotomy is neither possible nor safe. "
06/01/1982 - "Argon laser peripheral iridotomy appears to be a laser peripheral iridotomy appears to be a safe and effective means of treating primary angle closure glaucoma."
01/01/1999 - "To study the efficacy and safety of limited (180 degrees) argon laser peripheral iridoplasty (ALPI) as a first-line treatment for acute primary angle closure glaucoma (PACG) without the use of systemic anti-glaucomatous medications. "
12/01/1998 - "This study aimed to examine the intraocular pressure (IOP)-lowering effects and safety of immediate argon laser peripheral iridoplasty (ALPI) as a first-line treatment for acute primary angle-closure glaucoma (PACG). "
05/01/1993 - "[Efficacy of argon and Nd:YAG laser combined in the treatment of primary chronic closed-angle glaucoma]."
|3.||acceleratory factor from growth hormone (AcG)IBA
03/01/2014 - "The aim of this study was to report the characteristics of angle closure glaucoma (ACG) in eye clinic patients of University College Hospital (UCH), Ibadan, Nigeria. "
01/01/2014 - "In addition, the group of patients with chronic angle-closure glaucoma (ACG) from the Beijing Eye Study (n = 37) was merged with a group of patients with chronic ACG from the Tongren hospital (n = 52). "
09/01/2005 - "This study was conducted to determine the usefulness of peripheral anterior chamber depth assessment in angle-closure glaucoma (ACG) screening in Japanese subjects. "
08/01/2000 - "This study was conducted to compare anatomical parameters, thought to be responsible for causing angle closure glaucoma (ACG), among eyes having acute, subacute or chronic ACG. "
02/01/2015 - "In contrast, angle-closure glaucoma (ACG) was associated with higher IOP (p = 0.03; B: 0.14; OR: 1.15; 95% CI: 1.01, 1.30) but not with TLCPD (p = 0.98), after adjustment for age and anterior chamber depth. "
|4.||bimatoprost (Lumigan)FDA Link
01/01/2011 - "Efficacy of bimatoprost 0.03% in reducing intraocular pressure in patients with 360° synechial angle-closure glaucoma: a preliminary study."
01/01/2011 - "In this study, exclusively involving patients with 360° synechial angle-closure glaucoma and no visual potential, bimatoprost 0.03% treatment demonstrated a statistically significant IOP reduction. "
01/01/2011 - "To assess efficacy and safety profile of bimatoprost 0.03% in lowering intraocular pressure (IOP) in 360° synechial angle-closure glaucoma patients. "
08/01/2007 - "The aim of this study was to compare the long-term efficacy of bimatoprost 0.03% monotherapy in primary open angle glaucoma (POAG) versus primary chronic angle closure glaucoma (PCACG) eyes. "
12/01/2007 - "The aim of this study was to compare the intraocular pressure (IOP)-lowering effect of latanoprost and bimatoprost as primary therapy in patients with chronic angle-closure glaucoma (CACG) after peripheral iridotomy. "
|5.||Pilocarpine (Ocusert)FDA LinkGeneric
05/01/1999 - "The finding that pilocarpine increases angular width in patients with narrow angles indicates that this agent is useful for treating patients with narrow angles and angle closure glaucoma. "
06/01/1997 - "Pilocarpine has been well recognized as the drug of choice for acute angle-closure glaucoma. "
01/01/1997 - "A comparative study of Ocusert Pilo 40, intensive pilocarpine and low-dose pilocarpine in the initial treatment of primary acute angle-closure glaucoma."
04/01/1989 - "Pilocarpine, a first choice drug for primary angle closure glaucoma (PACG), is reported to produce shallow anterior chamber and posterior synechia and consequently a small immobile pupil. "
10/01/1984 - "The treatment of acute attack of primary angle-closure glaucoma by pilocarpine ocusert system."
|6.||Mitomycin (Mitomycin-C)FDA LinkGeneric
01/01/2015 - "To determine the occurrence of intraoperative and postoperative complications up to three years after primary phacotrabeculectomy with intraoperative use of Mitomycin C (MMC) in primary open angle (POAG) and primary angle closure glaucoma (PACG) patients, and the effect of postoperative complications on surgical outcome. "
03/01/2013 - "A total of 165 consecutive patients with primary angle-closure glaucoma (PACG) undergoing primary mitomycin-C-augmented trabeculectomy underwent a comprehensive eye examination before surgery and were followed-up on days 1, 7, 14, and 30, and months 3, 6, 12, and 18. "
03/01/2013 - "Can early postoperative intraocular pressure predict success following mitomycin-C augmented trabeculectomy in primary angle-closure glaucoma."
03/01/2004 - "To compare the results of small incision trabeculectomy avoiding Tenon's capsule (SIT) vis-à-vis intraoperative use of Mitomycin-C (MMC) in primary chronic angle closure glaucoma. "
01/01/2011 - "To compare the surgical outcomes of single site phacotrabeculectomy without mitomycin C (MMC) in primary angle-closure glaucoma (PACG) and primary open-angle glaucoma (POAG). "
|7.||Timolol (Blocadren)FDA LinkGeneric
04/01/2012 - "The present study investigates ocular hypotensive effect and systemic side effects of 0.1% timolol eye gel once daily compared with 0.5% timolol eye drop twice daily in patients with chronic angle-closure glaucoma. "
04/01/2012 - "Timolol 0.5% eye drop and 0.1% timolol eye gel effectively reduced IOP in chronic angle-closure glaucoma patients. "
04/01/2012 - "A comparison of 0.1% timolol eye gel and 0.5% timolol eye drop in patients with chronic angle-closure glaucoma."
01/01/1992 - "The reduction in intraocular pressure due to topical timolol was equal in the narrow angle and the open angle groups, but topical timolol did not protect against the development of angle-closure glaucoma or visual field loss."
07/01/1980 - "[Treatment of narrow-angle glaucoma with timolol (author's transl)]."
03/01/2007 - "To detect the objective structure changes of the retinal nerve fiber layer (RNFL) in primary acute angle closure glaucoma (PAACG) and to evaluate the efficacy of quantitative assessment of RNFL thickness with optical coherence tomography (OCT). "
03/01/2001 - "The aim of this study was to document the time-course of retinal dysfunction by pattern-electroretinography (PERG) in eyes of the DBA/2NNia substrain of mouse that develop an inherited angle-closure glaucoma. "
08/01/2015 - "PAX6 Expression and Retinal Cell Death in a Transgenic Mouse Model for Acute Angle-Closure Glaucoma."
03/01/2013 - "To investigate the association of quantitative 3-T diffusion tensor imaging (DTI) with retinal nerve fiber layer (RNFL) thickness measured by optical coherence tomography (OCT) and clinical severity in detecting optic nerve degeneration in patients with primary closed-angle glaucoma. "
09/01/2011 - "To observe the differences of damage patterns of retinal nerve fiber layer (RNFL) between acute and chronic intraocular pressure (IOP) elevation in primary angle closure glaucoma (PACG) using optical coherence tomography (OCT). "
|9.||travoprost (Travatan)FDA Link
08/01/2011 - "A 12-week, double-masked, parallel-group study of the safety and efficacy of travoprost 0.004% compared with pilocarpine 1% in Chinese patients with primary angle-closure and primary angle-closure glaucoma."
12/01/2006 - "The aim of this study was to compare the intraocular pressure (IOP)-lowering effect of latanoprost and travoprost as primary therapy in patients with chronic angle-closure glaucoma (CACG) after peripheral iridotomy. "
12/01/2006 - "Comparison of the effects of latanoprost and travoprost on intraocular pressure in chronic angle-closure glaucoma."
08/01/2011 - "To examine the intraocular pressure-lowering efficacy and safety of travoprost 0.004% and pilocarpine 1% in Chinese patients with primary angle-closure (PAC) and primary angle-closure glaucoma (PACG) after laser iridotomy in China. "
04/01/2013 - "To compare the intraocular pressure (IOP) lowering effect of 0.004% travoprost and 2% carteolol in patients with ocular hypertension (OHT) after laser peripheral iridotomy (LPI) or trabeculectomy in primary angle-closure glaucoma (PACG). "
04/01/2011 - "To evaluate corneal hysteresis (CH) and intraocular pressure (IOP) measured by the Ocular Response Analyzer in Chinese subjects with primary angle-closure glaucoma (PACG), assess their relationship with Goldmann applanation tonometry (GAT) measurements, and compare this with subjects with primary open-angle glaucoma (POAG) and normal controls. "
02/01/2009 - "Three hundred eyes of 100 healthy subjects, 100 patients with primary open angle glaucoma, and 100 patients with primary angle-closure glaucoma underwent IOP evaluation with DCT and GAT, and measurements of CCT, CC, and AL. Bland-Altman plots were used to evaluate the agreement between tonometers. "
01/01/2011 - "Open angle glaucoma (established or OHT high risk) in an adult populationIOP measurement by Goldmann applanation tonometry (the gold standard)Number and timing of IOP measurements explicitly reported (e.g., 5 measurements a day for 5 visits to generate a diurnal curve or 1 measurement a day [no diurnal curve] every 3 months for 2 years)IOP parameters include fluctuation (range [peak minus trough] or standard deviation) and meanOutcome measure = progression or development of glaucomaStudy reports results for ≥ 20 eyesMost recent publication if there are multiple publications based on the same study Angle closure glaucoma or pediatric glaucomaCase reportsIOP measured by a technique other than GAT (the gold standard)Number and timing of IOP measurements not explicitly reported Progression or development of glaucoma There is very low quality evidence (retrospective studies, patients on different treatments) for the use of a diurnal tension curve or single measurements to assess short or long-term IOP fluctuation or mean as a risk factor for the development or progression of glaucoma. "
01/01/1991 - "It thus appears that a combination of goniosynechialysis and laser gonioplasty may be effective in the management of refractory angle-closure glaucoma in the presence of an extremely narrow angle."
09/01/1987 - "While laser iridotomies have proven most effective in the treatment of acute angle-closure glaucoma, there is a diversity of opinion regarding the treatment of chronic forms, in particular when the congestive phase has been of long duration (e.g., 3 to 14 days). "
01/01/1996 - "The dark-room prone-position test could be useful in evaluating the pupillary block component in angle-closure glaucoma eyes and helpful in making a decision for laser iridotomy."
08/01/1992 - "Laser iridotomy is generally a safe and effective procedure for narrow-angle glaucoma. "
09/01/1991 - "During the past decade, laser iridotomy has replaced surgery as first-line treatment in angle-closure glaucoma. "
01/01/1977 - "In most cases, the angle-closure glaucoma associated with the plateau iris configuration is cured by a peripheral iridectomy. "
01/01/1979 - "Management of chronic or intermittent primary angle-closure glaucoma: a long-term follow-up of the results of peripheral iridectomy used as an initial procedure."
01/01/1975 - "The other group of patients had reversible angle-closure glaucoma associated with anatomically small anterior segments, and typically responded well to iridectomy. "
01/01/1974 - "Indentation gonioscopy and efficacy of iridectomy in angle-closure glaucoma."
04/01/1979 - "Measurement of anterior chamber volume is discussed and attention drawn to a new, convenient slit-image method, which was used to study anterior chamber depth and volume before and after prophylactic peripheral iridectomy in the fellow eyes of patients presenting with unilateral acute angle-closure glaucoma. "
02/01/2014 - "To evaluate the safety and efficacy of microcoaxial phacoemulsification combined with viscogoniosynechialysis in managing refractory acute angle-closure glaucoma (AACG) unresponsive to conventional therapy. "
04/01/2010 - "[Acute angle closure and angle closure glaucoma: Phacoemulsification as first-line treatment]."
08/01/2010 - "The purpose of this study was to evaluate the effectiveness of phacoemulsification and viscogoniosynechialysis in the management of patients with chronic angle-closure glaucoma (CACG). "
12/01/2015 - "To evaluate changes of anterior chamber angle (ACA) by anterior-segment optical coherence tomography (AS-OCT) in patients with primary angle closure glaucoma (PACG) following phacoemulsification (phaco) with or without goniosynechialysis (GSL). "
12/01/2015 - "Anterior Chamber Angle Assessment by Anterior-segment Optical Coherence Tomography After Phacoemulsification With or Without Goniosynechialysis in Patients With Primary Angle Closure Glaucoma."
04/01/2014 - "The purpose of this study was to evaluate changes in choroidal thickness (CT) in advanced or late-stage primary angle closure glaucoma (PACG) patients who had undergone trabeculectomy. "
01/01/2015 - "A 47-year-old female presented with bilateral secondary angle closure glaucoma with isolated microspherophakia, right subluxated lens and left operated trabeculectomy. "
12/01/2014 - "Ninety-seven consecutive patients with primary open-angle or angle-closure glaucoma underwent primary trabeculectomy. "
09/01/2014 - "Among 11, 1 patient (9%) who had undergone trabeculectomy had presented with acute on chronic angle closure glaucoma. "
09/01/2014 - "To evaluate the in vivo changes in the Schlemm's canal (SC) in patients with primary angle-closure glaucoma (PACG) after trabeculectomy using spectral-domain optical coherence tomography (SD-OCT). "
|5.||Intraocular Lens Implantation
01/01/2011 - "The effectiveness of early lens extraction with intraocular lens implantation for the treatment of primary angle-closure glaucoma (EAGLE): study protocol for a randomized controlled trial."
01/01/2010 - "Clear lens extraction and intraocular lens implantation in a case of microspherophakia with secondary angle closure glaucoma."
03/01/2009 - "Clinical reports of lensectomy with posterior chamber intraocular lens implantation in the treatment of acute, chronic, and secondary angle-closure glaucoma describe very favorable results. "
09/01/2008 - "To report a case of angle closure glaucoma after piggyback intraocular lens implantation and its treatment. "
09/01/2008 - "Angle-closure glaucoma after piggyback intraocular lens implantation."